Bill Parker    Chief Executive Officer     
  
   
   96 
  
    
  
   Normal 
   0 
   
   
   
   
   false 
   false 
   false 
   
   EN-US 
   X-NONE 
   X-NONE 
   
    
    
    
    
    
    
    
    
    
   
   
    
    
    
    
    
    
    
    
    
    
    
    
    
  
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
  
   
 
 /* Style Definitions */
table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;}
 
    Bill Parker brings a combination of operational discipline and personal compassion to his role as CEO of LeafLine Labs. Drawing on his military service and prior work experience, Bill understands the need for structure and precision in building trust and delivering consistent, high-quality results in this emerging industry. And, fueled by his experience in emergency medicine and his son's heroic battle with pediatric cancer, Bill is also deeply committed to helping relieve human suffering and believes medicinal cannabis offers a solution for many debilitating and life-threatening conditions.      Prior to being named CEO, Bill led Operations at LeafLine Labs for more than two years, introducing critical processes and best practices to a startup organization. Before joining LeafLine, Parker was employed as a paramedic for 14 years, working in both clinic and ambulance settings, with an emphasis on operations and emergency preparedness.  During that time, he witnessed firsthand the negative effects of opiates and addiction.    Parker also served in the United States Army for four years of active duty in field artillery. He spent one of those years in S2 and cross-trained in intelligence.    He is married with three children, meditates daily, and is passionate about spending time outdoors, especially fishing, with family and friends.

Bill Parker

Chief Executive Officer

Bill Parker brings a combination of operational discipline and personal compassion to his role as CEO of LeafLine Labs. Drawing on his military service and prior work experience, Bill understands the need for structure and precision in building trust and delivering consistent, high-quality results in this emerging industry. And, fueled by his experience in emergency medicine and his son's heroic battle with pediatric cancer, Bill is also deeply committed to helping relieve human suffering and believes medicinal cannabis offers a solution for many debilitating and life-threatening conditions.    

Prior to being named CEO, Bill led Operations at LeafLine Labs for more than two years, introducing critical processes and best practices to a startup organization. Before joining LeafLine, Parker was employed as a paramedic for 14 years, working in both clinic and ambulance settings, with an emphasis on operations and emergency preparedness.  During that time, he witnessed firsthand the negative effects of opiates and addiction.  

Parker also served in the United States Army for four years of active duty in field artillery. He spent one of those years in S2 and cross-trained in intelligence.  

He is married with three children, meditates daily, and is passionate about spending time outdoors, especially fishing, with family and friends.

  Dr. Angela Janis    Chief Medical Officer   Dr. Angela Janis is a board-certified psychiatrist in Madison, WI. She graduated from Washington University in St. Louis and the University of Illinois College of Medicine before completing a psychiatry residency at UW-Madison. She has most recently been working as Co-Director of Mental Health Services and Director of Psychiatry at University Health Services at the University of Wisconsin – Madison, which is ranked as the #1 student health service by Princeton Review.   She previously worked at Dean Clinic, providing outpatient services in Janesville, WI, and inpatient and ER consultation at St. Mary’s Hospital - Madison, where she served as Joint Medical Director of Consult Liaison Psychiatry.   Dr. Janis has been involved in organized medicine at many levels.  She currently serves on the Wisconsin Medical Society Board of Directors as well as on the Council on Legislation, Membership Committee, and WisMedPAC board and is Past President of the Dane County Medical Society. Dr. Janis serves as Secretary of the Wisconsin Psychiatric Association where she is also President of the Wisconsin Psychiatric Association PAC.    Dr. Janis is a passionate educator on the topic of cannabis, providing lectures to many different health care providers across the midwest. Additionally, she is very passionate about women’s health, and is Past President of the Wisconsin Alliance for Women’s Health and is Secretary of the Board of Directors for Physicians for Reproductive Health, a national organization of physicians promoting evidenced based reproductive health policies.

Dr. Angela Janis

Chief Medical Officer

Dr. Angela Janis is a board-certified psychiatrist in Madison, WI. She graduated from Washington University in St. Louis and the University of Illinois College of Medicine before completing a psychiatry residency at UW-Madison. She has most recently been working as Co-Director of Mental Health Services and Director of Psychiatry at University Health Services at the University of Wisconsin – Madison, which is ranked as the #1 student health service by Princeton Review.   She previously worked at Dean Clinic, providing outpatient services in Janesville, WI, and inpatient and ER consultation at St. Mary’s Hospital - Madison, where she served as Joint Medical Director of Consult Liaison Psychiatry. 

Dr. Janis has been involved in organized medicine at many levels.  She currently serves on the Wisconsin Medical Society Board of Directors as well as on the Council on Legislation, Membership Committee, and WisMedPAC board and is Past President of the Dane County Medical Society. Dr. Janis serves as Secretary of the Wisconsin Psychiatric Association where she is also President of the Wisconsin Psychiatric Association PAC.  

Dr. Janis is a passionate educator on the topic of cannabis, providing lectures to many different health care providers across the midwest. Additionally, she is very passionate about women’s health, and is Past President of the Wisconsin Alliance for Women’s Health and is Secretary of the Board of Directors for Physicians for Reproductive Health, a national organization of physicians promoting evidenced based reproductive health policies.

  Dave Sage    Chief   Financial Officer     
  
   
   96 
  
    
  
   Normal 
   0 
   
   
   
   
   false 
   false 
   false 
   
   EN-US 
   X-NONE 
   X-NONE 
   
    
    
    
    
    
    
    
    
    
   
   
    
    
    
    
    
    
    
    
    
    
    
    
    
  
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
  
   
 
 /* Style Definitions */
table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;}
 
  Dave graduated from the University of Minnesota in 1990 with a Bachelor of Science in Accounting and passed the CPA exam shortly thereafter.  He has 25+ years of accounting and finance experience in a broad range of industries including various manufacturing industries, retail, media and food distribution.  He has experience at startup companies with less than $10 million in annual sales to large Fortune 500 companies with $20 billion in annual revenues.    Dave excels in process improvements and building new processes from the ground up.  He takes pride in working well with all levels within an organization, which you do by treating everyone with respect and kindness, and also having fun while you’re at work.  At LeafLine Labs Dave is responsible for all financial aspects of the business.  Dave is involved with the local Prior Lake Athletics for Youth (PLAY) and has coached his daughters’ basketball and track teams over the last 7 years.  He was born and raised in Minnesota and has called Prior Lake home for the last 20 years.  He is engaged to his best friend Jodi and they have 3 daughters and 3 dogs to keep them busy.

Dave Sage

Chief Financial Officer

Dave graduated from the University of Minnesota in 1990 with a Bachelor of Science in Accounting and passed the CPA exam shortly thereafter.  He has 25+ years of accounting and finance experience in a broad range of industries including various manufacturing industries, retail, media and food distribution.  He has experience at startup companies with less than $10 million in annual sales to large Fortune 500 companies with $20 billion in annual revenues.  

Dave excels in process improvements and building new processes from the ground up.  He takes pride in working well with all levels within an organization, which you do by treating everyone with respect and kindness, and also having fun while you’re at work.  At LeafLine Labs Dave is responsible for all financial aspects of the business.

Dave is involved with the local Prior Lake Athletics for Youth (PLAY) and has coached his daughters’ basketball and track teams over the last 7 years.  He was born and raised in Minnesota and has called Prior Lake home for the last 20 years.  He is engaged to his best friend Jodi and they have 3 daughters and 3 dogs to keep them busy.

  Emily Kowalski    Director of Cultivation     
  
   
   96 
  
    
  
   Normal 
   0 
   
   
   
   
   false 
   false 
   false 
   
   EN-US 
   X-NONE 
   X-NONE 
   
    
    
    
    
    
    
    
    
    
   
   
    
    
    
    
    
    
    
    
    
    
    
    
    
  
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
  
   
 
 /* Style Definitions */
table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;}
 
  Emily Kowalski knows that quality plants have the power to improve quality of life. She manages cultivation at our indoor facility with a commitment to patients, safety, quality, and efficiency.   Kowalski earned her B.S. in Horticulture from the University of Wisconsin – Madison. She integrates her knowledge and experience in propagation, greenhouse production, and outdoor nursery production to increase the standards of medical cannabis cultivation.  As Director of Cultivation, Kowalski applies her expertise in horticultural operations management to produce consistent, healthy cannabis in LeafLine’s state of the art production facility.    Kowalski’s passion for horticulture grew from gardening as a child with her mother. Her enthusiasm for plants extends beyond LeafLine to all of the green spaces she experiences.

Emily Kowalski

Director of Cultivation

Emily Kowalski knows that quality plants have the power to improve quality of life. She manages cultivation at our indoor facility with a commitment to patients, safety, quality, and efficiency. 

Kowalski earned her B.S. in Horticulture from the University of Wisconsin – Madison. She integrates her knowledge and experience in propagation, greenhouse production, and outdoor nursery production to increase the standards of medical cannabis cultivation.

As Director of Cultivation, Kowalski applies her expertise in horticultural operations management to produce consistent, healthy cannabis in LeafLine’s state of the art production facility.  

Kowalski’s passion for horticulture grew from gardening as a child with her mother. Her enthusiasm for plants extends beyond LeafLine to all of the green spaces she experiences.

  Rachel Loeber, PhD    Chief Scientific Officer   Dr. Rachel Loeber is a medicinal chemist by training with extensive experience in analytical chemistry, organic chemistry, and pharmacology.  She earned her B.S. from the University of Wisconsin – River Falls with a dual major in Biochemistry and Biotechnology followed by a Ph.D. in Medicinal Chemistry in the laboratory of Dr. Natalia Tretyakova at the University of Minnesota’s Masonic Cancer Center.  Her research focused on gaining a better understanding of the chemical mechanisms of carcinogenesis and the therapeutic actions of anti-tumor drugs.  At LeafLine Labs, Dr. Loeber oversees both production and R&D activities involving cannabis extraction, medical cannabis formulation, analytical testing, and regulatory compliance.  She has drawn from her previous industrial laboratory experience to bring scientific rigor and good laboratory practices to LeafLine Labs, differentiating them as a leader in the ever-evolving medical cannabis industry.   Dr. Loeber enjoys networking with other scientists and is an active member of numerous scientific and cannabis-specific interest groups.

Rachel Loeber, PhD

Chief Scientific Officer

Dr. Rachel Loeber is a medicinal chemist by training with extensive experience in analytical chemistry, organic chemistry, and pharmacology.  She earned her B.S. from the University of Wisconsin – River Falls with a dual major in Biochemistry and Biotechnology followed by a Ph.D. in Medicinal Chemistry in the laboratory of Dr. Natalia Tretyakova at the University of Minnesota’s Masonic Cancer Center.  Her research focused on gaining a better understanding of the chemical mechanisms of carcinogenesis and the therapeutic actions of anti-tumor drugs.

At LeafLine Labs, Dr. Loeber oversees both production and R&D activities involving cannabis extraction, medical cannabis formulation, analytical testing, and regulatory compliance.  She has drawn from her previous industrial laboratory experience to bring scientific rigor and good laboratory practices to LeafLine Labs, differentiating them as a leader in the ever-evolving medical cannabis industry. 

Dr. Loeber enjoys networking with other scientists and is an active member of numerous scientific and cannabis-specific interest groups.

  Ryan McNamara  
  
   
   96 
  
    
  
   Normal 
   0 
   
   
   
   
   false 
   false 
   false 
   
   EN-US 
   X-NONE 
   X-NONE 
   
    
    
    
    
    
    
    
    
    
   
   
    
    
    
    
    
    
    
    
    
    
    
    
    
  
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
  
   
 
 /* Style Definitions */
table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;}
 
      Director of Formulation and Product Development     
  
   
   96 
  
    
  
   Normal 
   0 
   
   
   
   
   false 
   false 
   false 
   
   EN-US 
   X-NONE 
   X-NONE 
   
    
    
    
    
    
    
    
    
    
   
   
    
    
    
    
    
    
    
    
    
    
    
    
    
  
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
  
   
 
 /* Style Definitions */
table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;}
 
  Ryan McNamara is a formulation scientist with over ten years of pharmaceutical industry experience.  Ryan earned a Bachelor of Science degree in Biology with a Chemistry minor from MSU.  Over the last decade, Ryan has had the unique experience of developing a wide range of pharmaceutical dosage forms including immediate release/modified release tablets, capsules, topical gels and creams, oral suspensions, suppositories, and pessaries. He is also well versed in GMP/GLP documentation practices, process research and scale up, production packaging and automation, and FDA/USP guidance.  Ryan brings the scientific rigor of the pharmaceutical industry to LeafLine Labs while stressing the importance of using organic and plant based ingredients over synthetic additives whenever possible. This guiding principle allows LeafLine to make safe, effective, and consistent medicine for our patients.  When not in the laboratory creating new medical cannabis products, Ryan can be found traveling the world and enjoying the great outdoors. One of his greatest accomplishments was trekking through the Himalayas to 17,800 feet through Thorung La, which is the highest pass in the world located in Nepal.   

Ryan McNamara

Director of Formulation and Product Development

Ryan McNamara is a formulation scientist with over ten years of pharmaceutical industry experience.  Ryan earned a Bachelor of Science degree in Biology with a Chemistry minor from MSU.  Over the last decade, Ryan has had the unique experience of developing a wide range of pharmaceutical dosage forms including immediate release/modified release tablets, capsules, topical gels and creams, oral suspensions, suppositories, and pessaries. He is also well versed in GMP/GLP documentation practices, process research and scale up, production packaging and automation, and FDA/USP guidance.

Ryan brings the scientific rigor of the pharmaceutical industry to LeafLine Labs while stressing the importance of using organic and plant based ingredients over synthetic additives whenever possible. This guiding principle allows LeafLine to make safe, effective, and consistent medicine for our patients.

When not in the laboratory creating new medical cannabis products, Ryan can be found traveling the world and enjoying the great outdoors. One of his greatest accomplishments was trekking through the Himalayas to 17,800 feet through Thorung La, which is the highest pass in the world located in Nepal.